Results 71 to 80 of about 149,321 (265)
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe
Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis +4 more
wiley +1 more source
Quality of life of patients with schizophrenia and its determinants
Introduction: As mortality rates are decreasing, thanks to new inventions and discoveries, morbidity rates are probably on the rise. Schizophrenia is a chronic mental disorder mostly requiring lifelong maintenance treatment.
Smitha Ramadas, Vyjayanthi Bonanthaya
doaj +1 more source
Patient Satisfaction and Oral Health-Related Quality of Life with Complete Dentures
Introduction: The purpose of complete dentures is to restore oral function and aesthetics for individuals with missing teeth. Understanding the relationship relating patient satisfaction and “Oral Health-Related Quality of Life (OHRQoL)” with complete ...
Kunchala Sailasri +6 more
doaj +1 more source
Homophily‐adjusted social influence estimation
Abstract Homophily and social influence are two key concepts of social network analysis. Distinguishing between these phenomena is difficult, and approaches to disambiguate the two have been primarily limited to longitudinal data analyses. In this study, we provide sufficient conditions for valid estimation of social influence through cross‐sectional ...
Hanh T.D. Pham, Daniel K. Sewell
wiley +1 more source
Background: Trismus, a common complication of oral squamous cell carcinoma (OSCC) treatment, can significantly affect patients’ quality of life (QoL). Understanding its prevalence and impact is crucial for improving patient care.
Anita Mohanty +5 more
doaj +1 more source
When setting the price of cell and gene therapies in Japan, the factors considered include the manufacturing and operating costs of the new drug or a comparator, leading to discrepancies between price and values, in particular those specific to cell and gene therapies.
Akina Takami, Ataru Igarashi
wiley +1 more source
Significance of correcting magnesium deficiency in different groups of women in surgical menopause
Background. In the 21st century, there is a clear trend towards an increase in the proportion of women with climacteric syndrome (CS) and surgical menopause.
D. V. Blinov +7 more
doaj +1 more source

